MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prime Medicine (PRME) Ownership - Who owns Prime Medicine?
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more
Profile
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
234.78M
P/E Ratio
N/A
Total Cash
190.44M
Projected Growth
N/A
Total Debt
40.79M
Revenue
2.98M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.45
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
PRME
Capitalization
235M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
190M
Total Cash/Share
1.45
Total Debt
40.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
2.98M
ROE
N/A
Book Value
153M
P/B Ratio
1.53
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.58
Current Revenue Per Employee
10200.93
Dividends Per Share - Security
N/A
EBITDA
-196.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-79.73
Shares Held By Institutions
725M
Shares Outstanding - Current
131M
Total Liabilities
144M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.699
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com